Compounds > ammonium tungsten antimonate hydroxide oxide
Page last updated: 2024-09-04

ammonium tungsten antimonate hydroxide oxide and ribavirin

ammonium tungsten antimonate hydroxide oxide has been researched along with ribavirin in 6 studies

Compound Research Comparison

Studies
(ammonium tungsten antimonate hydroxide oxide)		Trials
(ammonium tungsten antimonate hydroxide oxide)		Recent Studies (post-2010)
(ammonium tungsten antimonate hydroxide oxide)		Studies
(ribavirin)		Trials
(ribavirin)		Recent Studies (post-2010) (ribavirin)
402012,3161,8805,443

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19906 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hirsch, MS; Kaplan, JC1
Broder, S; Yarchoan, R1
Sandström, E1
Fauci, AS; Lane, HC1
Marwick, C; Riesenberg, DE1
Castagna, A; Crocchiolo, P; Lazzarin, A; Moroni, M; Orlando, G; Verani, P1

Reviews

4 review(s) available for ammonium tungsten antimonate hydroxide oxide and ribavirin

ArticleYear
Prospects of therapy for infections with human T-lymphotropic virus type III.
    Annals of internal medicine, 1985, Volume: 103, Issue:5

    Topics: Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; Antimony; Antiviral Agents; Combined Modality Therapy; Deltaretrovirus; Foscarnet; Humans; Immunotherapy; Interferons; Lactams, Macrocyclic; Phosphonoacetic Acid; Receptors, Virus; Reverse Transcriptase Inhibitors; Ribavirin; RNA Processing, Post-Transcriptional; RNA, Viral; Suramin; Tungsten; Tungsten Compounds; Virus Replication

1985
Progress in the development of antiviral therapy for HTLV-III-associated diseases.
    Important advances in oncology, 1987

    Topics: Acquired Immunodeficiency Syndrome; Antimony; Antiviral Agents; Foscarnet; HIV; Humans; Phosphonoacetic Acid; Ribavirin; Rifabutin; Rifamycins; Suramin; Thymidine; Tungsten; Tungsten Compounds; Zidovudine

1987
Antiviral drugs for AIDS. Current status and future prospects.
    Drugs, 1986, Volume: 31, Issue:6

    Topics: Acquired Immunodeficiency Syndrome; Antimony; Antiviral Agents; Foscarnet; Humans; Interferon Type I; Phosphonoacetic Acid; Ribavirin; Suramin; Thymidine; Tungsten; Tungsten Compounds; Zidovudine

1986
Immunologic reconstitution in the acquired immunodeficiency syndrome.
    Annals of internal medicine, 1985, Volume: 103, Issue:5

    Topics: Acquired Immunodeficiency Syndrome; Adjuvants, Immunologic; Antimony; Antiviral Agents; Bone Marrow Transplantation; Deltaretrovirus; Humans; Immunotherapy; Interferon Type I; Interferon-gamma; Interleukin-2; Lymphocyte Transfusion; Ribavirin; Suramin; Thymus Gland; Tungsten; Tungsten Compounds

1985

Other Studies

2 other study(ies) available for ammonium tungsten antimonate hydroxide oxide and ribavirin

ArticleYear
Anti-AIDS agents show varying early results in vitro and in vivo.
    JAMA, 1985, Nov-08, Volume: 254, Issue:18

    Topics: Acquired Immunodeficiency Syndrome; Antimony; Antiviral Agents; Deltaretrovirus; Humans; Ribavirin; Suramin; Thymidine; Tungsten; Tungsten Compounds; Zidovudine

1985
Therapeutic trials with HPA23, alpha-IFN and ribavirin in AIDS patients.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1987, Volume: 6, Issue:2 Suppl

    Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Antimony; Antiviral Agents; Humans; Interferon Type I; Ribavirin; Ribonucleosides; Tungsten; Tungsten Compounds

1987